Texan Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-23,063
Closed -$3.74M 150
2015
Q4
$3.74M Sell
23,063
-215
-0.9% -$33.8K 1.68% 13
2015
Q3
$3.22M Sell
23,278
-1,320
-5% -$208K 1.42% 17
2015
Q2
$3.78M Buy
24,598
+2,433
+11% +$390K 1.52% 12
2015
Q1
$3.54M Sell
22,165
-5,815
-21% -$916K 1.94% 9
2014
Q4
$4.46M Sell
27,980
-4,910
-15% -$765K 1.97% 9
2014
Q3
$4.62M Sell
32,890
-55
-0.2% -$7.18K 1.95% 10
2014
Q2
$3.9M Buy
32,945
+20,020
+155% +$2.32M 1.69% 5
2014
Q1
$1.59M Buy
12,925
+250
+2% +$30.3K 0.73% 49
2013
Q4
$1.45M Buy
+12,675
New +$1.44M 0.74% 43

Other funds holding AMGN

Texan Capital Management's AMGN Position: Q1 2016 in Review

Texan Capital Management sold out of Amgen (AMGN) in Q1 2016, closing a stake of 23,063 shares — an estimated $3.74M sold.

Texan Capital Management first reported a position in AMGN in Q4 2013 and held it in 9 quarters. The position peaked at $4.62M in Q3 2014. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Texan Capital Management reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Texan Capital Management sold 23,063 Amgen shares in Q1 2016, an estimated $3.74M.
  • Texan Capital Management first reported a position in Amgen in Q4 2013 and held it in 9 quarters.
  • Texan Capital Management's Amgen position peaked at $4.62M in Q3 2014.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Texan Capital Management's 13F filing for Q1 2016, filed 11 May 2016.